Partnering With a CRO: Ways CROs Solve Pharmaceutical Sponsor Challenges The Contribution of Pharmaceuticals to Drug DevelopmentThe pharmaceutical industry has emerged as a driving force behind revolutionary advancements in drug development. Over the years, it has transformed how drugs and medications are manufactured, designed, and identified, increasing the efficacy of global drug development. From personalized…
Sharing lessons learned from our most recent event! NoyMed is proud to announce that through the efforts of our organizational team and our speakers Armen Margaryan, Hripsime Petrosyan, MBA, Vahagn Melkonyan, Kristine Gevorgyan, and Davit Davtyan, the “Clinical Trial Perspective in Armenia” forum successfully took place on September 5, 2023, in Yerevan, Armenia!This event was a milestone in our commitment to…
Early Phase Clinical Trials What are Early Phase Clinical Trials? Early phase clinical trials are the first step in testing new treatments in humans. These trials are typically small and involve a limited number of patients. The goals of early phase clinical trials include finding the maximum tolerated dose (MTD), determining the long-term and short-term…
Announcing Our Upcoming Event: “Clinical Trial Perspective in Armenia” We are excited to announce an exclusive event that holds the potential to shape the future of clinical research in Armenia. NoyMed CRO is proud to present the event “Clinical Trials’ Perspective in Armenia,” scheduled to take place on September 5th, 2023, at 16:00 in the…
Precision Medicine in 2023 Clinical Trials What is Precision Medicine? Precision medicine, also called personalized medicine, revolutionizes healthcare through an innovative omics-based strategy that employs DNA, RNA, and protein analyses for disease identification, prevention, and treatment. High-throughput omics technologies facilitate data-rich analyses essential for this approach, providing comprehensive biological insights, while advanced data processing supports…
We’ve Moved our Headquarters to a New Location: Glendale Plaza, Regus Business Center We are thrilled to share a significant milestone in our company’s journey – our recent headquarters relocation to Glendale Plaza, Regus Business Center! As our team continues to grow and evolve, we realized the need for a space that aligns with our…
Introduction: Drug discovery and development are time-consuming, costly, and extremely risky, taking over 10-15 years and costing $314 million to $2.8 billion on average. Despite the risks and costs, 90% of drug candidates reaching Phase 1 clinical trials fail. Clinical trials are essential for developing and evaluating the safety and efficacy of new drugs, medications, medical devices, surgical…
Introduction Innovation and emerging technologies play a pivotal role in revolutionizing the Global Clinical Trials Industry, benefiting both researchers and participants. Technological advancements have ushered in heightened efficiency, precision, and patient-focused research methodologies, revolutionizing areas such as patient recruitment and engagement, data handling, personalized medicine, regulatory adherence, and remote monitoring. These transformative tools are reshaping the landscape…
Introduction The journey from the laboratory to market approval for new drugs is a complex process that demands precision, expertise, and efficiency. In the clinical research industry, where time is often a critical factor, a Contract Research Organization (CRO) is vital in accelerating the time-to-market for new drugs and medications. In this article, we will…
Introduction: Data is the lifeblood of clinical trials and clinical research. It is used to make decisions about the safety and effectiveness of new treatments, to identify new targets for drug development, and to improve the way that patients are cared for. In recent years, the volume and complexity of data generated by clinical trials…
